SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Tuesday reported third-quarter profit of $68.5 million.

The San Diego-based company said it had profit of 69 cents per share.

The results did not meet Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 84 cents per share.

The biopharmaceutical company posted revenue of $387.9 million in the period, surpassing Street forecasts. Eleven analysts surveyed by Zacks expected $378 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News